CMS Releases National Coverage Determination on Next Generation Sequencing
Published on: March 21, 2018
The final policy will allow local Medicare Administrative
Contractors to continue to provide coverage for NGS-based tests that are not
automatically covered by the NCD. Several local coverage determinations
that provide coverage for hematological malignancies will now remain in effect.
CMS expanded the coverage portion of the policy as well. NGS-based tests will be covered under the NCD when the following
requirements are met: